Diseases & Conditions >
This topic is from The 5-Minute Pain Management Consult About our sources

Fabry’s Disease Updated 4/2010

Email       Print Section  |  Print Topic       Add to My Favorites

BASICS

  • Description
  • Epidemiology
  • Risk Factors
  • Pathophysiology
  • Etiology

DIAGNOSIS

  • Signs and Symptoms
  • Tests
  • Differential Diagnosis
  • Medication (Drugs)
  • Rehabilitation
  • Mental Health/Behavioral
  • Special Therapy

Follow-up

  • Prognosis
  • Complications
  • Patient Monitoring
The following is an excerpt....
BASICS
Description
  • Fabry’s disease was named after Johannes Fabry’s, dermatologist.
  • It is a disorder of glycosphingolipid metabolism.
  • A deficiency in α-galactosidase A (α-Gal A).
  • Also known as:
    • –Angiokeratoma corporis diffusum universale
    • –Alpha-galactosidase A deficiency
    • –Alpha-Gal A deficiency
    • –Ceramide trihexosidase
  • X-Linked disease
  • Typically fatal in men by the fifth decade of life and in women by the seventh decade
  • Primary manifestation:
    • –Cutaneous, cardiovascular, cerebrovascular, renal, neurologic, psychiatric
ALERT: Pediatric Considerations
  • Alpha-Gal A deficiency presents in male children and female young adults.
  • Prenatal and postnatal testing is available.
Epidemiology
Prevalence
  • Fabry’s disease presents in 1 of 40,000 births.
  • Presents in all races.
Risk Factors
Genetics
  • X-linked inheritance pattern
  • Gene defect is ...

You must be logged in to fully access this content.

Sign In
Sign up for a 30-Day Free Trial

Sign up for a 30-Day FREE Trial now and receive access to all content.

Start free trial!

Have a book code?

Submit your book code to create your FREE standard account.
See Also
Diseases & Conditions >
Related Subjects